MC1991A1 - Esters d'acides carboxyliques pharmacologiquement actifs - Google Patents
Esters d'acides carboxyliques pharmacologiquement actifsInfo
- Publication number
- MC1991A1 MC1991A1 MC882016A MC2016A MC1991A1 MC 1991 A1 MC1991 A1 MC 1991A1 MC 882016 A MC882016 A MC 882016A MC 2016 A MC2016 A MC 2016A MC 1991 A1 MC1991 A1 MC 1991A1
- Authority
- MC
- Monaco
- Prior art keywords
- carboxylic acid
- acid esters
- pharmacologically active
- active carboxylic
- pharmacologically
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
- C07D501/22—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with radicals containing only hydrogen and carbon atoms, attached in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D463/00—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D463/10—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
- C07D463/14—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hetero atoms directly attached in position 7
- C07D463/16—Nitrogen atoms
- C07D463/18—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof
- C07D463/20—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D463/22—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen further substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
- C07D477/02—Preparation
- C07D477/06—Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents
- C07D477/08—Modification of a carboxyl group directly attached in position 2, e.g. esterification
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
- C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
- C07D501/36—Methylene radicals, substituted by sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D505/00—Heterocyclic compounds containing 5-oxa-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cephalosporin Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH457087 | 1987-11-24 | ||
CH316588 | 1988-08-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
MC1991A1 true MC1991A1 (fr) | 1989-11-30 |
Family
ID=25692354
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MC882016A MC1991A1 (fr) | 1987-11-24 | 1988-11-21 | Esters d'acides carboxyliques pharmacologiquement actifs |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP0318767A3 (fr) |
JP (1) | JPH01165585A (fr) |
KR (1) | KR890008082A (fr) |
AU (1) | AU614793B2 (fr) |
DK (1) | DK637888A (fr) |
FI (1) | FI885330A (fr) |
HU (1) | HU207522B (fr) |
IL (1) | IL88403A0 (fr) |
MC (1) | MC1991A1 (fr) |
NO (1) | NO885221L (fr) |
NZ (1) | NZ226989A (fr) |
PT (1) | PT89080B (fr) |
SU (1) | SU1598880A3 (fr) |
YU (2) | YU216188A (fr) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL99898A (en) * | 1990-11-09 | 1996-10-31 | Eisai Co Ltd | 7-Noble-3- Compounds Transformed Carbamoylloxy |
BR9608318A (pt) * | 1995-05-03 | 1999-01-26 | Smithkline Beecham Plc | Esteres de carbapenems |
JP2014525459A (ja) * | 2011-08-31 | 2014-09-29 | マリンクロッド エルエルシー | H−ホスホネート−エン/h−ホスホネート−インヒドロホスホニル化反応を用いた標的化ナノ粒子のリモートアセンブリ |
MX352760B (es) | 2011-09-09 | 2017-12-07 | Merck Sharp & Dohme Corp Star | Metodos para tratar infecciones intrapulmonares. |
US8809314B1 (en) | 2012-09-07 | 2014-08-19 | Cubist Pharmacueticals, Inc. | Cephalosporin compound |
US8476425B1 (en) | 2012-09-27 | 2013-07-02 | Cubist Pharmaceuticals, Inc. | Tazobactam arginine compositions |
US20140275000A1 (en) | 2013-03-15 | 2014-09-18 | Cubist Pharmaceuticals, Inc. | Ceftolozane pharmaceutical compositions |
MX2020004205A (es) | 2013-03-15 | 2021-11-16 | Merck Sharp & Dohme Llc | Composiciones antibioticas de ceftolozano. |
US9872906B2 (en) | 2013-03-15 | 2018-01-23 | Merck Sharp & Dohme Corp. | Ceftolozane antibiotic compositions |
WO2015035376A2 (fr) | 2013-09-09 | 2015-03-12 | Calixa Therapeutics, Inc. | Traitement d'infections au moyen de ceftolozane/tazobactam chez des sujets ayant une fonction rénale altérée |
US20150094293A1 (en) | 2013-09-27 | 2015-04-02 | Calixa Therapeutics, Inc. | Solid forms of ceftolozane |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2476087A1 (fr) * | 1980-02-18 | 1981-08-21 | Roussel Uclaf | Nouvelles oximes derivees de l'acide 3-alkyloxy ou 3-alkyl-thiomethyl 7-amino thiazolyl acetamido cephalosporanique, leur procede de preparation et leur application comme medicaments |
JPS5984889A (ja) * | 1982-11-05 | 1984-05-16 | Sumitomo Chem Co Ltd | セフアロスポリン誘導体およびその製造方法 |
-
1988
- 1988-11-15 DK DK637888A patent/DK637888A/da not_active Application Discontinuation
- 1988-11-17 EP EP19880119145 patent/EP0318767A3/fr not_active Withdrawn
- 1988-11-17 FI FI885330A patent/FI885330A/fi not_active Application Discontinuation
- 1988-11-17 IL IL88403A patent/IL88403A0/xx unknown
- 1988-11-17 NZ NZ226989A patent/NZ226989A/en unknown
- 1988-11-21 AU AU25785/88A patent/AU614793B2/en not_active Ceased
- 1988-11-21 JP JP63292541A patent/JPH01165585A/ja active Pending
- 1988-11-21 MC MC882016A patent/MC1991A1/fr unknown
- 1988-11-21 HU HU885974A patent/HU207522B/hu unknown
- 1988-11-22 KR KR1019880015325A patent/KR890008082A/ko not_active Application Discontinuation
- 1988-11-23 SU SU884356966A patent/SU1598880A3/ru active
- 1988-11-23 NO NO88885221A patent/NO885221L/no unknown
- 1988-11-24 PT PT89080A patent/PT89080B/pt not_active IP Right Cessation
- 1988-11-24 YU YU02161/88A patent/YU216188A/xx unknown
-
1989
- 1989-10-03 YU YU01915/89A patent/YU191589A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
HU207522B (en) | 1993-04-28 |
DK637888D0 (da) | 1988-11-15 |
YU216188A (en) | 1990-04-30 |
EP0318767A2 (fr) | 1989-06-07 |
KR890008082A (ko) | 1989-07-08 |
YU191589A (en) | 1991-02-28 |
EP0318767A3 (fr) | 1991-03-20 |
SU1598880A3 (ru) | 1990-10-07 |
NZ226989A (en) | 1992-05-26 |
FI885330A (fi) | 1989-05-25 |
NO885221L (no) | 1989-05-25 |
IL88403A0 (en) | 1989-06-30 |
AU614793B2 (en) | 1991-09-12 |
NO885221D0 (no) | 1988-11-23 |
DK637888A (da) | 1989-05-25 |
JPH01165585A (ja) | 1989-06-29 |
HUT48895A (en) | 1989-07-28 |
PT89080B (pt) | 1993-04-30 |
PT89080A (pt) | 1988-12-01 |
AU2578588A (en) | 1989-05-25 |
FI885330A0 (fi) | 1988-11-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0302349A3 (en) | Biologically active carboxylic acid esters | |
DK406686D0 (da) | Carboxylsyrederivater | |
NO173547C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolonkarboksylsyrederivater | |
IT1217573B (it) | Benzammidi sostituite farmacologicamente attive | |
MC1991A1 (fr) | Esters d'acides carboxyliques pharmacologiquement actifs | |
FR2609474B1 (fr) | Procede de synthese electrochimique d'acides carboxyliques | |
KR860700122A (ko) | 데글루코테이코플라닌의 카트복실산 에스테르 유도체 | |
FR2602229B1 (fr) | Procede de preparation d'esters d'acides carboxyliques insatures | |
MC1981A1 (fr) | Derives d'acides catechol carboxyliques | |
BE893324A (fr) | Preparation d'esters d'acides carboxyliques | |
FR2687667B1 (fr) | Esters d'acides carboxyliques d'hydroxyphenylalcanols comme stabilisants. | |
IT8222566A0 (it) | Derivato dell'acido ursolico farmacologicamente attivo. | |
IT8820990A0 (it) | Esteri penem 6 sostituiti come agenti antinfiammatori e antidegenerativi. | |
DK670589A (da) | Carboxylsyrederivater | |
FR2566434B1 (fr) | Procede d'electrosynthese d'acides carboxyliques | |
BE893322A (fr) | Preparation d'acides carboxyliques | |
DE69229616D1 (de) | Enzymatische Resolution von Alpha-tertiären-Karbonsäureestern | |
BE893419A (fr) | Production d'acides carboxyliques et d'esters | |
DE69030774D1 (de) | Optisch aktive Diastereoisomersalze von Tetrahydro-2-furancarbonsäure | |
FR2637594B1 (fr) | Preparation d'amides d'acides carboxyliques | |
NZ223684A (en) | Guanidine carboxylic acid esters and pharmaceutical compositions | |
DK576687D0 (da) | Terapeutisk aktive alkensyrederivater | |
NO932002D0 (no) | Nye tiosemikarbazonsyreestere | |
ZA888616B (en) | Esters of pharmacologically active carboxylic acids | |
IL87072A0 (en) | Biologically active carboxylic acid esters |